In the Phase 2 obesity data the weight curve was still trending downward at 48 weeks, so a genuine plateau at a tolerated maintenance dose may simply reflect the body settling toward a new set point rather than the protocol failing
Discard any remaining solution after that, even if the vial still has liquid in it
Instead, slowly and gently push the plunger, allowing the water to run down the side of the glass and pool at the bottom
Research by Godet and Marie examined the effects of GHK-Cu on osteoblastic cell spreading, attachment, and phenotype
Because it does not suppress appetite, it can theoretically be combined with GLP-1 agonists to add a lipolytic component to the appetite suppression mechanism, though clinical data on this combination is lacking
however it is not FDA approved for this area